Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 13, 2015
Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy
David John Mott, Mehdi Najafzadeh
BMC Infectious Diseases
|
October 22, 2016
Increasing incidence associated with herpes zoster infection in British Columbia, Canada
Fawziah Marra, Mei Chong, Mehdi Najafzadeh
Pharmacoeconomics
|
November 8, 2017
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety
Mehdi Najafzadeh, Jorge A Garces, Alejandra Maciel
Clinical Pharmacology and Therapeutics
|
October 17, 2017
Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses
Mehdi Najafzadeh, Joshua J Gagne, Sebastian Schneeweiss
Journal of Clinical Epidemiology
|
May 20, 2008
Reliability studies of diagnostic tests are not using enough observers for robust estimation of interobserver agreement: a simulation study
Mohsen Sadatsafavi, Mehdi Najafzadeh, Larry Lynd, et al.
Personalized Medicine
|
January 11, 2014
Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment
Alexandra Elizabeth Shields, Mehdi Najafzadeh, Anna Boonin Schachter
American Journal of Medical Genetics. Part A
|
February 28, 2013
Barriers for integrating personalized medicine into clinical practice: a qualitative analysis
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, et al.
Pharmacoepidemiology and Drug Safety
|
July 6, 2010
A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework
Larry D Lynd, Carlo A Marra, Mehdi Najafzadeh, et al.
Pharmacoeconomics
|
November 14, 2009
Cost effectiveness of herpes zoster vaccine in Canada
Mehdi Najafzadeh, Carlo A Marra, Eleni Galanis, et al.
BMJ (Clinical Research Ed.)
|
July 19, 2019
Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis
David G Li, Mehdi Najafzadeh, Aaron S Kesselheim, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 13, 2015
Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy
David John Mott, Mehdi Najafzadeh
BMC Infectious Diseases
|
October 22, 2016
Increasing incidence associated with herpes zoster infection in British Columbia, Canada
Fawziah Marra, Mei Chong, Mehdi Najafzadeh
Pharmacoeconomics
|
November 8, 2017
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety
Mehdi Najafzadeh, Jorge A Garces, Alejandra Maciel
Clinical Pharmacology and Therapeutics
|
October 17, 2017
Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses
Mehdi Najafzadeh, Joshua J Gagne, Sebastian Schneeweiss
Journal of Clinical Epidemiology
|
May 20, 2008
Reliability studies of diagnostic tests are not using enough observers for robust estimation of interobserver agreement: a simulation study
Mohsen Sadatsafavi, Mehdi Najafzadeh, Larry Lynd, et al.
Personalized Medicine
|
January 11, 2014
Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment
Alexandra Elizabeth Shields, Mehdi Najafzadeh, Anna Boonin Schachter
American Journal of Medical Genetics. Part A
|
February 28, 2013
Barriers for integrating personalized medicine into clinical practice: a qualitative analysis
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, et al.
Pharmacoepidemiology and Drug Safety
|
July 6, 2010
A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework
Larry D Lynd, Carlo A Marra, Mehdi Najafzadeh, et al.
Pharmacoeconomics
|
November 14, 2009
Cost effectiveness of herpes zoster vaccine in Canada
Mehdi Najafzadeh, Carlo A Marra, Eleni Galanis, et al.
BMJ (Clinical Research Ed.)
|
July 19, 2019
Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis
David G Li, Mehdi Najafzadeh, Aaron S Kesselheim, et al.
Page
of 6